The activity of AMPK, a negative regulator of mTOR signaling, increased by 2-fold when treated with quercetin at 15μM, in both MDA-MB-231 and MDA-MB-435 BC cells (Fig 2). The gene discussed is MTOR; the disease is breast cancer.